Therefore, to investigate the relationship between E2, ERβ and IL6 in lung cancer and test the hypothesis that E2 up-regulates IL6 through ERβ to promote lung cancer progression, in the present study, we demonstrate that both IL6 and ERβ expression regulate clinicopathological factors in NSCLC. The gene discussed is ESR2; the disease is lung cancer.